Search

everythinglearnresearchcommunity

for

Search:↓

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Higher androgen levels do not cause baldness in men.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

A new gene, JMJD1C, may affect testosterone levels in men.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

SHBG may be a useful early indicator and treatment target for PCOS.